Caren Deardorf

Insider Reports History

Entity
Individual
Location
C/O Magenta Therapeutics, Inc., 100 Technology Square, Cambridge, Massachusetts
Signature
Marc Wilson, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Caren Deardorf:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Crinetics Pharmaceuticals, Inc. Director Common Stock 9.4K $446K $47.49 Jun 7, 2024 Direct
Magenta Therapeutics, Inc. Chief Commercial Officer Common Stock 19.8K $237K $12.00 Nov 30, 2022 Direct
Crinetics Pharmaceuticals, Inc. Director Stock Option (right to buy) 12.5K Jun 7, 2024 Direct

Insider Reports Filed by Caren Deardorf

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CRNX Crinetics Pharmaceuticals, Inc. Jun 7, 2024 2 $0 4 Jun 11, 2024 Director
CRNX Crinetics Pharmaceuticals, Inc. Jun 16, 2023 2 $0 4 Jun 21, 2023 Director
MGTA Magenta Therapeutics, Inc. Nov 30, 2022 1 $2.82K 4 Dec 2, 2022 Chief Commercial Officer
MGTA Magenta Therapeutics, Inc. Aug 1, 2022 1 $0 4 Aug 1, 2022 Chief Commercial Officer
CRNX Crinetics Pharmaceuticals, Inc. Jun 17, 2022 1 $0 4 Jun 21, 2022 Director
MGTA Magenta Therapeutics, Inc. May 31, 2022 1 $2.97K 4 Jun 6, 2022 Chief Commercial Officer
MGTA Magenta Therapeutics, Inc. May 17, 2022 1 $0 4 May 19, 2022 Chief Commercial Officer
CRNX Crinetics Pharmaceuticals, Inc. Mar 11, 2022 1 $0 4/A Apr 4, 2022 Director
CRNX Crinetics Pharmaceuticals, Inc. Mar 11, 2022 0 $0 3 Mar 14, 2022 Director
MGTA Magenta Therapeutics, Inc. Feb 15, 2022 1 $0 4 Feb 17, 2022 Chief Commercial Officer
MGTA Magenta Therapeutics, Inc. Sep 16, 2021 1 -$42K 4 Sep 20, 2021 Chief Commercial Officer
MGTA Magenta Therapeutics, Inc. Sep 14, 2021 1 $0 4 Sep 16, 2021 Chief Commercial Officer
MGTA Magenta Therapeutics, Inc. Jul 6, 2021 1 $0 4 Jul 8, 2021 Chief Commercial Officer
MGTA Magenta Therapeutics, Inc. Jul 6, 2021 0 $0 3 Jul 8, 2021 Chief Commercial Officer